<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>National Heart and Lung Institute</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6D93C4B4-6A1A-4858-8A69-03438AAFF1FC"><gtr:id>6D93C4B4-6A1A-4858-8A69-03438AAFF1FC</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Denning</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/826273D7-CE6F-46DF-ACD7-5FBFB3745FDC"><gtr:id>826273D7-CE6F-46DF-ACD7-5FBFB3745FDC</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Schneider</gtr:surname><gtr:orcidId>0000-0001-9645-1938</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8757FBA7-07CE-4F4E-9510-AEBCDBE73724"><gtr:id>8757FBA7-07CE-4F4E-9510-AEBCDBE73724</gtr:id><gtr:firstName>Sian</gtr:firstName><gtr:otherNames>E</gtr:otherNames><gtr:surname>Harding</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FL012618%2F1"><gtr:id>155F29F8-338C-40EA-9C6D-D1C7289CAA46</gtr:id><gtr:title>BHF Imperial Cardiovascular Regenerative Medicine Centre</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/L012618/1</gtr:grantReference><gtr:abstractText>The BHF UK Regenerative Medicine Centre at Imperial College and Nottingham focuses on the heart muscle cell, and there are two main aspects to the research. First, patient-derived blood or skin cells can be turned into beating heart muscle cells, and it has been shown that they can have the characteristics of the heart disease seen in the patient. This allows us to investigate them as a &amp;quot;disease-in-a-dish&amp;quot; model and work out drug treatments or gene therapy specific for that type of patient. One very useful aspect of the stem cells is the ability to grow them in large numbers. To take advantage of that, new machines are being developed to screen multiple cells simultaneously. Both Imperial and Nottingham have experience in designing these large-scale experiments. We wish to purchase a number of state-of-the-art machines, shared between Imperial and Nottingham; develop cell models and assays for these; then make them available to the Regenerative Medicine community. Second, we aim to make muscle grafts from the stem cell-derived heart cells and to implant them in disease models in rats and mice to assess whether they will provide repair. We have used an MRI machine to do this previously, but ours has been decommissioned. We are asking for a contribution to the purchase of another MRI, and for its housing at Imperial in the building where the majority of Cardiovascular Regenerative Medicine researchers work, and next to other imaging machines which we will also use.</gtr:abstractText><gtr:technicalSummary>We plan a suite of high content/automated imaging platforms for the assessment of the cardiomyocyte phenotype with complementary capabilities at Imperial and Nottingham. This will allow complete phenotyping of a given endogenous, reprogrammed or pluripotent-stem cell derived cardiomyocyte by the Imperial/Nottingham Centre. The cardiomyocyte from embryonic (hESC-CM) or induced pluripotent (iPSC-CM) stem cells represents a human genotype-specific cell with an authentic morphological, electrical and contractile phenotype. For investigation of development, disease modelling and target discovery, the high throughput capabilities of stem cell-derived cardiomyocytes have the potential to produce a step-change in scale for the cardiac cell biology researcher. This will mesh with the increasing number of small- and large-scale initiatives to produce patient-derived pluripotent stem cells to model cardiac disease. Academics will also be well placed to transfer laboratory-based medium-throughput studies directly to Industry assays where similar platforms are used. We also ask for a contribution to the purchase and housing of new MRI scanner which will replace the instrument previously supported by the MRC CSC at Imperial. The proposed site for the MRI is the basement of the Imperial Centre for Translational and Experimental Medicine (ICTEM), where the majority of Imperial PIs are based. The proposed new facility will house Magnetic Resonance (MR), Positron Emission Tomography - Computed Tomography (PET-CT) and In-Vivo Imaging System (IVIS) scanning equipment together with associated support areas. The MRI is essential for the phenotyping of animals after interventions to increase cardiac stem-cell derived muscle integration, and we have developed state-of-the-art image analysis algorithms for these experiments in rodent disease models.</gtr:technicalSummary><gtr:potentialImpactText>The immediate beneficiary in terms of health is the cardiovascular patient population. Collectively, heart and circulatory diseases cause more than a quarter of all deaths in the UK, accounting for more than 159,000 deaths each year. The cost of premature death, lost productivity, hospital treatment and prescriptions is estimated at &amp;pound;19 billion. The primary reason for the decline into heart failure is loss of the muscle capacity of the heart, and the effectiveness of Left Ventricular Assist Devices shows that restoring power keeps the patient alive. Our centre aims focuses of the degeneration into heart failure and aims to address the problem of preparing and maintaining the cardiac graft, or stimulating the natural repair processes. This will have relevance for the 750,000 or more people living with heart failure in the UK.

The development of the iPSC-CM as a tool for target and drug discovery has potential to widen the benefitting group to all aetiologies of disease and to build a bridge between the researcher and the pharmaceutical industry. Assays for high throughput screening developed in an academic laboratory can be transferred directly to the companies. Genotype-specific solutions points the way to a stratified medicine strategy, increasing the effectiveness of therapy. As well as this, the off-target effects of non-cardiac drugs to produce cardiotoxicity, a known problem for industry, can be addressed. The success of models of long QT syndrome has pointed the way, and now the cardiotoxic effects of cancer chemotherapeutic agents is being studied extensively. This will be of importance in the cancer survivor cohort who are increasingly long-lived.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-03-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-12-31</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>714591</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Heart and Lung Repair Shop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1991D6E6-B9C8-4DE1-9510-58406CC6073C</gtr:id><gtr:impact>A retail unit in Kings Mall Hammersmith was converted into a shop to engage the public in activities around our research. It was staffed 11-5pm with evening activities also. I manned this for several days and one evening


More than 2000 visitors of all ages came to the shop and the various demonstrations.</gtr:impact><gtr:outcomeId>5461e0e39e6bf1.90866478</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF Science in Store</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BD4DC889-27C0-46ED-966A-6EE7F43F21CF</gtr:id><gtr:impact>Designing and setting up activities in a BHF Furniture store. Towards a potential UK-wide initiative</gtr:impact><gtr:outcomeId>58ac3b01ba5486.87235056</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Heart and Lung Convenience Store</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>61E075C7-D452-4899-B790-9DA79332BFC2</gtr:id><gtr:impact>2 week pop up shop in local Mall</gtr:impact><gtr:outcomeId>58ac2cd6925bf1.46936947</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRACKIT Scheme</gtr:description><gtr:end>2014-05-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>6EBA4C55-F41B-4CB7-93C4-37FD68AC6BD3</gtr:id><gtr:outcomeId>5461d9417f2bc0.51654737</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>152776</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Clinical Research Training Fellowship</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>FS/15/79/31736</gtr:fundingRef><gtr:id>262C8C67-5C08-4DA3-A9FB-B555ABAF64E0</gtr:id><gtr:outcomeId>56e00362c58d69.61248912</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>215481</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Clinical Research Training Fellowship - Richard Jabbour:</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef> FS/16/17/31663</gtr:fundingRef><gtr:id>FAA3F329-33DC-4FC2-A974-E64A91BFBF7C</gtr:id><gtr:outcomeId>56de8fadd78133.24345680</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>714000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Capital call for Regenerative Medicine</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L012618/1</gtr:fundingRef><gtr:id>30B0FAF4-6823-4B78-8DAB-0DD5C6EB0E1F</gtr:id><gtr:outcomeId>5461d833130710.21495439</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>487000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK-China Stem Cell Partnership Initiative</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M010422/1</gtr:fundingRef><gtr:id>977C07A6-1065-4111-A2D5-6D8364F80F6D</gtr:id><gtr:outcomeId>56e00651cd2385.67717031</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK Regenerative Medicine Platform</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L022699/1</gtr:fundingRef><gtr:id>7BE2C371-727C-41AC-B498-CCB155A8952E</gtr:id><gtr:outcomeId>56e0057dc196e7.42809473</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF UK cardiovascular Regenerative Medicine Centre</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>4DD48DEE-DCCC-4321-8A49-A364FA0A06A3</gtr:id><gtr:outcomeId>537b01066aca1</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Special advisor to the House of Commons Science and Technology Select Committee report on Regenerative Medicine</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C6C0E934-A231-4378-A71D-C24F8D245E34</gtr:id><gtr:outcomeId>58ac3bccdd79c6.36739465</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2028203B-40A5-4629-BAE2-2F2C9DFFFDF3</gtr:id><gtr:title>Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/774adde14d69c12426f5b7e4aac46b56"><gtr:id>774adde14d69c12426f5b7e4aac46b56</gtr:id><gtr:otherNames>Dixon JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>585d5dfb94b671.35808221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F541D93A-B4CE-4731-9B7D-2222706DE730</gtr:id><gtr:title>Aberrant a-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44f93743e559aafdfa1e2921addae87e"><gtr:id>44f93743e559aafdfa1e2921addae87e</gtr:id><gtr:otherNames>F?ldes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>56de8e5c1b9d96.53802159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4755A8BE-912F-4EC7-AD39-4D046A3CDA8F</gtr:id><gtr:title>PDGFRa demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69f683a0294f8623647160e859318df6"><gtr:id>69f683a0294f8623647160e859318df6</gtr:id><gtr:otherNames>Noseda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d5b6ec2aa05.07292821</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40D48E92-9C53-4414-B6FE-09083F07CB7C</gtr:id><gtr:title>Induced pluripotent stem cell-derived cardiac myocytes to understand and test calcium handling: Pie in the sky?</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcadfc130cad972a1c0bd5af04c45f43"><gtr:id>bcadfc130cad972a1c0bd5af04c45f43</gtr:id><gtr:otherNames>Kane C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>58ac2b4a958bd1.04587472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E8C2CD2-969D-485B-91B9-6CA8EC0B6F67</gtr:id><gtr:title>A conducting polymer with enhanced electronic stability applied in cardiac models.</gtr:title><gtr:parentPublicationTitle>Science advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1d9301db34ee84c5cd348e26b382a82"><gtr:id>f1d9301db34ee84c5cd348e26b382a82</gtr:id><gtr:otherNames>Mawad D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2375-2548</gtr:issn><gtr:outcomeId>58ac2b4b30edd8.17259610</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DFA374C-9EF4-485C-9ED9-85101B4E6E2C</gtr:id><gtr:title>Excitation-contraction coupling of human induced pluripotent stem cell-derived cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Frontiers in cell and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcadfc130cad972a1c0bd5af04c45f43"><gtr:id>bcadfc130cad972a1c0bd5af04c45f43</gtr:id><gtr:otherNames>Kane C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2296-634X</gtr:issn><gtr:outcomeId>58ac2b4a70a243.70704149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ABCBB82-5BD7-4D19-903F-26CB295104AB</gtr:id><gtr:title>Immunosuppressive agents modulate function, growth, and survival of cardiomyocytes and endothelial cells derived from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44f93743e559aafdfa1e2921addae87e"><gtr:id>44f93743e559aafdfa1e2921addae87e</gtr:id><gtr:otherNames>F?ldes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>5461cfceb6b756.68115819</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03A1FF93-C109-4898-B1AF-E612FC095158</gtr:id><gtr:title>The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b07428a4302e1145f8a778124d7a524"><gtr:id>3b07428a4302e1145f8a778124d7a524</gtr:id><gtr:otherNames>Rao C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>5461e70d1224e4.61659246</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA7549A1-E35B-4BFC-B6AB-95869E6AC419</gtr:id><gtr:title>Surface Chemistry and Microtopography of Parylene C Films Control the Morphology and Microtubule Density of Cardiac Myocytes.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part C, Methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ced3da3a497877490428ac4e3d67ebb"><gtr:id>6ced3da3a497877490428ac4e3d67ebb</gtr:id><gtr:otherNames>Trantidou T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1937-3384</gtr:issn><gtr:outcomeId>58ac2b4b01fe17.56544362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEC20247-58B5-4205-86BA-F25EE24135F4</gtr:id><gtr:title>Morphology and vasoactive hormone profiles from endothelial cells derived from stem cells of different sources.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6876405508e7bf34fb809ea1df37d15"><gtr:id>c6876405508e7bf34fb809ea1df37d15</gtr:id><gtr:otherNames>Reed DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>56de8e5bdc4e08.87330595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>064CD23B-A4F8-4022-9F2C-09BF7F39E67B</gtr:id><gtr:title>Signaling via PI3K/FOXO1A pathway modulates formation and survival of human embryonic stem cell-derived endothelial cells.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a110ebdeccd99f9c75317b59b59a9202"><gtr:id>a110ebdeccd99f9c75317b59b59a9202</gtr:id><gtr:otherNames>Merkely B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>56de8e5c404d26.18560115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD27A086-A889-4FE3-A2EB-851552CC73D1</gtr:id><gtr:title>Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56de8d9be5e048.83363417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>590EF5B4-8FD0-4A8E-8FBB-B6C37768221B</gtr:id><gtr:title>Pathogen sensing pathways in human embryonic stem cell derived-endothelial cells: role of NOD1 receptors.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6876405508e7bf34fb809ea1df37d15"><gtr:id>c6876405508e7bf34fb809ea1df37d15</gtr:id><gtr:otherNames>Reed DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5461cfce3b0055.95393301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FC92541-C047-4DF9-A862-0BFFD24107C1</gtr:id><gtr:title>Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dc533ec61bcb06d365d185e0dabeb1f"><gtr:id>1dc533ec61bcb06d365d185e0dabeb1f</gtr:id><gtr:otherNames>Denning C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>585d5641dd6140.64078668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB580830-63DF-49C5-8889-653F0578F6AF</gtr:id><gtr:title>G-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease Modeling.</gtr:title><gtr:parentPublicationTitle>Frontiers in cell and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5980770a56483304ab0518d00761b00e"><gtr:id>5980770a56483304ab0518d00761b00e</gtr:id><gtr:otherNames>Dolatshad NF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2296-634X</gtr:issn><gtr:outcomeId>56de8d48d276f6.99662799</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA38DE09-7AE6-4978-9989-8422015E8B05</gtr:id><gtr:title>Poly(3-hydroxyoctanoate), a promising new material for cardiac tissue engineering.</gtr:title><gtr:parentPublicationTitle>Journal of tissue engineering and regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38a1faaec7b46c9f185a4e70247ff6b7"><gtr:id>38a1faaec7b46c9f185a4e70247ff6b7</gtr:id><gtr:otherNames>Bagdadi AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6254</gtr:issn><gtr:outcomeId>58ac2bae3304d5.86413792</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>636439D1-2FE4-49F8-88F7-911484174FF0</gtr:id><gtr:title>Five colour variants of bright luminescent protein for real-time multicolour bioimaging.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94ef51efba953dd8ac8f84b9ab5cfc10"><gtr:id>94ef51efba953dd8ac8f84b9ab5cfc10</gtr:id><gtr:otherNames>Suzuki K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58ac28f310f684.12741581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4428CB5-1739-49EE-B30C-E153F62F79E5</gtr:id><gtr:title>Large stem cell-derived cardiomyocyte grafts: cellular ventricular assist devices?</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccdf10bde26fd91c579ac35551d5ee49"><gtr:id>ccdf10bde26fd91c579ac35551d5ee49</gtr:id><gtr:otherNames>Harding SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>5461cfce135c12.25050652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC5EE073-9858-4F2A-80BE-1D91911A81F2</gtr:id><gtr:title>Biorealistic cardiac cell culture platforms with integrated monitoring of extracellular action potentials.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ced3da3a497877490428ac4e3d67ebb"><gtr:id>6ced3da3a497877490428ac4e3d67ebb</gtr:id><gtr:otherNames>Trantidou T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58ac2b4a169582.43103694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81D5C6F0-BFBF-413D-BD62-CABBDB0CF6AF</gtr:id><gtr:title>Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand?</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdaafd6c6982f21324856ab367eeb82a"><gtr:id>fdaafd6c6982f21324856ab367eeb82a</gtr:id><gtr:otherNames>Gouadon E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>56de8d9bc3cea6.62036885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3191ECC2-5EFB-43F4-A016-9DEF8BA4D062</gtr:id><gtr:title>Heart regeneration.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93db92cd97ed94a6596091df54be53e9"><gtr:id>93db92cd97ed94a6596091df54be53e9</gtr:id><gtr:otherNames>Breckwoldt K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>58ac28f33823d1.94658715</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B7481A5-E9BA-4013-A5E2-CF4D3ACA3F74</gtr:id><gtr:title>The Fallacy of Assigning Chamber Specificity to iPSC Cardiac Myocytes from Action Potential Morphology.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcadfc130cad972a1c0bd5af04c45f43"><gtr:id>bcadfc130cad972a1c0bd5af04c45f43</gtr:id><gtr:otherNames>Kane C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>58ac2b4aca4008.45883310</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>318125E9-87BD-4749-A808-BE7449B2E0D5</gtr:id><gtr:title>Identification of polymer surface adsorbed proteins implicated in pluripotent human embryonic stem cell expansion.</gtr:title><gtr:parentPublicationTitle>Biomaterials science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12624f7c7748d454dbff9720d6c307a4"><gtr:id>12624f7c7748d454dbff9720d6c307a4</gtr:id><gtr:otherNames>Hammad M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-4830</gtr:issn><gtr:outcomeId>585d366f4c83f3.21115265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25E0860A-F1B6-4701-954D-B33C101BF638</gtr:id><gtr:title>Action potential morphology of human induced pluripotent stem cell-derived cardiomyocytes does not predict cardiac chamber specificity and is dependent on cell density.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c973549e5329fa047f361ff1b2b767b"><gtr:id>3c973549e5329fa047f361ff1b2b767b</gtr:id><gtr:otherNames>Du DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>58ac2b49ddb734.98420842</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/L012618/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>